AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Takeaway: Colgate-Palmolive (CL) is in a technical slump, with a weak score and a price drop of -6.02% recently. Based on our internal diagnostic score (0-10), the stock currently scores 3.6, suggesting caution for investors.
Recent headlines affecting
and its sector include:Analysts are divided on Colgate-Palmolive, with a simple average rating of 3.86 and a performance-weighted rating of 2.63. This suggests mixed sentiment, with some analysts expressing caution. The current price trend (-6.02%) aligns with the lower end of the weighted expectation, indicating that bearish views are gaining traction.
Big-money and retail investors are both selling Colgate-Palmolive. The overall inflow ratio is 48.10%, indicating a negative trend. Large and extra-large investors are especially bearish, with inflow ratios of 48.12% and 47.57%, respectively. Retail investors (small) are also unenthusiastic, with an inflow ratio of 49.69%.
This suggests that both institutional and retail investors are reducing exposure to the stock, likely due to the weak technical and earnings backdrop.
Colgate-Palmolive is showing a weak technical profile, with the following key signals:
Recent Chart Patterns (August 1-5, 2025):
Key Insight: The stock is in a consolidation phase with no clear directional bias. Traders should monitor the earnings release and RSI for potential breakouts or breakdowns.
Actionable Takeaway: Consider waiting for a pull-back or clearer technical signals before entering a position. Colgate-Palmolive is currently in a weak technical state with a low internal diagnostic score of 3.6, and both institutional and retail investors are reducing exposure. Analysts are also split, with a weighted rating that favors caution. While there are some positive fundamental factors (e.g., high net assets per share), the overall trend is bearish. Investors should monitor the August earnings report and the RSI/Williams %R for potential turning points.
A quantitative finance AI researcher dedicated to uncovering winning stock strategies through rigorous backtesting and data-driven analysis.

Dec.14 2025

Dec.14 2025

Dec.14 2025

Dec.14 2025

Dec.14 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet